NEW BRUNSWICK, N.J.,
Nov. 6, 2020 /PRNewswire/ -- Johnson
& Johnson (NYSE: JNJ) will hold a virtual Medical Devices
Update for the investment community on Thursday, November 19, 2020, in which leadership
will focus on the Company's differentiated and competitive
platforms across digital surgery and provide franchise and
innovation highlights across the Johnson & Johnson Medical
Devices Companies.
"We look forward to providing an update on the strength of our
Medical Devices business and how we are positioning ourselves for
long-term success through meaningful innovation that will continue
to make a difference for patients around the world," said
Ashley McEvoy, Executive Vice
President, Worldwide Chairman, Medical Devices, Johnson &
Johnson.
The Update will include:
- Franchise exhibits, available for viewing anytime after
4:30 p.m. ET on November 18, 2020:
-
- Orthopaedics, Surgery, Interventional Solutions and Vision
franchise and innovation highlights
- General session on November 19,
2020 beginning at 10 a.m. ET
and scheduled to end at approximately 12:30
p.m. ET:
-
- Opening remarks from Ashley
McEvoy, Executive Vice President, Worldwide Chairman,
Medical Devices, Johnson & Johnson
- A review of the Company's digital strategy and capabilities
- Two live Q&A sessions, including one with select Johnson
& Johnson Medical Devices Companies clinical experts leading
our digital strategy, followed by a session with members of our
Medical Devices leadership team
The franchise exhibits and general session will showcase many
distinguished leaders from across Johnson & Johnson,
including:
- Frederic H. Moll,*
MD, Chief Development Officer, Medical Devices
- William N. Hait,† MD,
PhD, Global Head, Johnson & Johnson External Innovation
- Avrum Spira,‡ MD,
MSc., Global Head, Lung Cancer Initiative at Johnson &
Johnson
- Peter Schulam,§ MD,
PhD, Chief Medical Officer, Medical Devices
- Peter Shen, PhD, Global Head,
Research & Development, Medical Devices
Additional leaders from the Company and an external key opinion
leader will also participate in the event to provide their
perspectives throughout the presentations and exhibits.
Those planning to attend the virtual event can register at
jnjmdupdate.virtualsession.events.
A replay of the event will be posted on the Investor Relations
section of the jnj.com website by the end of the day on
November 19, 2020.
About Johnson & Johnson
At Johnson & Johnson, we believe good health is the
foundation of vibrant lives, thriving communities and forward
progress. That's why, for more than 133 years, we have aimed to
keep people well at every age and every stage of life. Today, as
the world's largest and most broadly based healthcare company, we
are committed to using our reach and size for good. We strive to
improve access and affordability, create healthier communities, and
put a healthy mind, body and environment within reach of everyone,
everywhere. We are blending our heart, science and ingenuity to
profoundly change the trajectory of health for humanity.
*Frederic
Moll is an employee of Auris Health, Inc., which was
acquired by Ethicon, Inc. in
2019
†William
Hait is an employee of Johnson & Johnson Innovation,
LLC
‡Avrum
Spira is an employee of Johnson & Johnson Enterprise
Innovation, Inc.
§Peter Schulam is an employee of Johnson &
Johnson
Peter Shen is an
employee of Johnson & Johnson
Note to Investors Concerning Forward-Looking
Statements
This press release contains "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995
regarding, among other things: future operating and financial
performance, product development, market position and business
strategy. The reader is cautioned not to rely on these
forward-looking statements. These statements are based on current
expectations of future events. If underlying assumptions prove
inaccurate or known or unknown risks or uncertainties materialize,
actual results could vary materially from the expectations and
projections of Johnson & Johnson. Risks and uncertainties
include, but are not limited to: economic factors, such as interest
rate and currency exchange rate fluctuations; competition,
including technological advances, new products and patents attained
by competitors; challenges inherent in new product research and
development, including uncertainty of clinical success and
obtaining regulatory approvals; uncertainty of commercial success
for new and existing products; challenges to patents; the impact of
patent expirations; the ability of the company to successfully
execute strategic plans; the impact of business combinations and
divestitures; manufacturing difficulties or delays, internally or
within the supply chain; product efficacy or safety concerns
resulting in product recalls or regulatory action; significant
adverse litigation or government action, including related to
product liability claims; changes to applicable laws and
regulations, including tax laws and global healthcare reforms;
trends toward healthcare cost containment; changes in behavior and
spending patterns of purchasers of healthcare products and
services; financial instability of international economies and
legal systems and sovereign risk; and increased scrutiny of the
healthcare industry by government agencies. A further list and
descriptions of these risks, uncertainties and other factors can be
found in Johnson & Johnson's Annual Report on Form 10-K for the
fiscal year ended December 29, 2019,
including in the sections captioned "Cautionary Note Regarding
Forward-Looking Statements" and "Item 1A. Risk Factors," and in the
company's most recently filed Quarterly Report on Form 10-Q, and
the company's subsequent filings with the Securities and Exchange
Commission. Copies of these filings are available online at
www.sec.gov, www.jnj.com or on request from Johnson & Johnson.
Any forward-looking statement made in this release speaks only as
of the date of this release. Johnson & Johnson does not
undertake to update any forward-looking statement as a result of
new information or future events or developments.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-to-host-virtual-medical-devices-update-301167855.html
SOURCE Johnson & Johnson